Advertisement

Topics

Roche stösst mit Immun-Therapeutikum Tecentriq in UK auf Widerstand

03:52 EDT 3 Aug 2017 | FinanzNachrichten

Basel/London (awp) - Roche stösst mit seinem Immun-Therapeutikum Tecentriq (Atezolizumab) in Grossbritannien bei der Zulassungsbehörde National Institute for Health and Clinical Excellence (NICE) a...

Original Article: Roche stösst mit Immun-Therapeutikum Tecentriq in UK auf Widerstand

NEXT ARTICLE

More From BioPortfolio on "Roche stösst mit Immun-Therapeutikum Tecentriq in UK auf Widerstand"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...